FOLD

FOLD R&D Expense Growth

24.21%Fiscal year

Period ending:

FOLD FY R&D Growth (YoY)%
FOLD FY R&D Growth (YoY)175.91%-129.56%
2003-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

FOLD r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 23 observations from Dec 31, 2003 to Dec 31, 2025.

Amicus Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
24.2141%
-28.2312%
-44.9246%
1.7012%
-11.7993%
7.7049%
5.7128%
81.4359%
42.4809%
36.1956%
61.5635%
13.5419%
-16.5675%
-1.1464%
30.2597%
-18.7995%
27.3197%
21.5293%
-7.6011%
146.3459%
0%
-100%
0%

Compare r&d expense growth

All FOLD financial metrics · FOLD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.